What a scoping review of 92 studies found about interim analyses

Adaptive trial designs get plenty of methodological attention. The specific mechanics of the interim analysis, the point where accumulating data is actually reviewed and a decision gets made about whether and how the trial adapts, get comparatively little. A scoping review that screened 6,720 articles down to 101 included articles representing 92 unique studies set out to map what's actually known about doing this part well, and found the practical guidance thinner than the volume of adaptive trial literature overall might suggest.

Four areas of practice the review could actually point to

Despite the evidence gaps, the review did identify four consistent areas of recommended practice worth treating as a genuine baseline:

• Protocol-level planning. Interim analyses need detailed planning set out in the protocol from the start, including preparing all patient information sheet variants for possible changes in advance, rather than drafting them reactively once an interim result actually triggers a change. This matters because a delay in getting updated participant-facing materials ready is exactly the kind of friction that can slow down acting on an interim finding once it's made.
• Stakeholder communication. Effective collaboration across the trial team, proper staff training, and quick resolution of site queries were all identified as recurring elements of interim analyses that went well. An interim analysis is only as timely as the data feeding it, and site-level query backlogs are a direct drag on that timeliness.
• Data management infrastructure. Electronic data capture systems with automated workflows and integrated quality checks featured consistently in the practices associated with high-quality interim analyses, unsurprising given that an interim look is only as trustworthy as the data quality behind it at the moment it's taken.
• Data integrity. Secure databases with established, defined data transfer procedures rounded out the fourth area, addressing the more basic question of whether the data reaching the interim analysis is complete and unaltered in transit.

None of these four areas is exotic. What's notable is that the review needed to identify them as a distinct set of best practices at all, suggesting they aren't yet universally embedded as standard operating procedure across adaptive trials generally.

The gaps are arguably more important than the practices

The review's account of what's missing from the literature is, if anything, more informative than its account of what's present. Four gaps stood out:

• Limited guidance specifically on interim analyses, despite a substantial body of literature on adaptive trial conduct more broadly. The interim analysis is the operational hinge point of an adaptive design, and it's the part with comparatively the least specific guidance behind it.
• Minimal evidence on patient and public involvement in interim decision-making. Decisions made at an interim analysis can materially affect participants already enrolled, whether through a design change, a dose adjustment, or a stopping decision, and the review found little evidence addressing how patients or the public are meaningfully involved in that process.
• Insufficient guidance on statistical approaches specific to adaptive trials' interim analyses. This is a genuinely surprising gap given how much attention adaptive trial statistics receive generally; the review suggests the interim-analysis-specific statistical guidance hasn't kept pace with the broader methodological literature.
• Few robust studies on real-world operational implementation. Plenty of literature describes adaptive trial design in principle. Comparatively little examines what actually happens operationally when a trial team executes an interim analysis in practice, the kind of on-the-ground detail that would help the next trial team avoid the same friction.

Why the gap between practice and evidence matters operationally

A trial team planning an adaptive design with interim analyses is, on this review's evidence, working with more established guidance on the trial's overall adaptive structure than on the specific operational moment where that structure actually gets exercised. That's a real risk, since the interim analysis is where planning meets execution under time pressure, accumulating data needs to be clean, complete, and reviewable fast enough for the decision to still be useful, and the review found comparatively little robust operational research to draw on for exactly this step.

What this means for planning an adaptive trial

A few practical takeaways follow directly:

• Don't assume general adaptive trial guidance covers the interim analysis specifically. The review's finding that guidance here is comparatively thin is a reason to treat the interim analysis planning as its own distinct exercise, not an assumed subset of the broader adaptive design plan.
• Invest in the four identified practice areas concretely, not just in principle. Protocol-level interim planning, stakeholder communication processes, EDC systems with automated quality checks, and secure, well-defined data transfer procedures are all specific, buildable elements, not vague aspirations.
• Build a mechanism for patient involvement in interim decisions, even a modest one, given how little evidence currently exists here. The absence of established guidance is itself a reason to think carefully about this rather than skip it as unaddressed by precedent.
• Treat data readiness for an interim look as a continuous requirement, not a point-in-time scramble. A study whose data pipeline is only ever clean at the point of an interim analysis, rather than continuously, is recreating exactly the kind of last-minute pressure the review's identified best practices are designed to avoid.

The broader message is that adaptive trials are only as adaptive as their interim analyses are timely and trustworthy, and a review of this scale finding real gaps in the operational evidence base for that specific step is a useful prompt to plan for it deliberately, rather than assume it's already covered by the surrounding literature on adaptive design.